DarioHealth (DRIO) Expected to Announce Earnings on Thursday

DarioHealth (NASDAQ:DRIO) will likely be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect DarioHealth to post earnings of ($0.24) per share and revenue of $7.39 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

DarioHealth Price Performance

Shares of DRIO stock opened at $0.70 on Tuesday. The stock has a 50 day moving average price of $0.68 and a 200 day moving average price of $0.81. DarioHealth has a 52-week low of $0.56 and a 52-week high of $1.93. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.32 and a current ratio of 1.57. The firm has a market capitalization of $29.10 million, a P/E ratio of -0.74 and a beta of 1.42.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on DRIO. TD Cowen downgraded DarioHealth from a “buy” rating to a “hold” rating and decreased their target price for the stock from $2.00 to $1.00 in a research report on Wednesday, January 29th. Stifel Nicolaus dropped their target price on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.